Ascletis Pharma (china) Co., Limited

This study tests an investigational injection called ASC30 for chronic weight management in people with obesity. About 115 adults aged 18–65 who are non-smokers and generally healthy will receive either the drug or a placebo. The main goal is to check safety and how the body proc…

This study tests an experimental tablet called ASC30 in 100 adults with type 2 diabetes. The goal is to see if it can lower blood sugar and help with weight over 13 weeks compared to a placebo. Participants must have stable weight and a BMI of 23 or higher. The study is active bu…